Searchable abstracts of presentations at key conferences in endocrinology

ea0090p417 | Pituitary and Neuroendocrinology | ECE2023

A negative association between growth hormone secretion and inflammation in adult patients with non-functioning pituitary mass

Seki Yasufumi , Bokuda Kanako , Morimoto Satoshi , Watanabe Satoshi , Yamashita Kaoru , Takano Noriyoshi , Watanabe Daisuke , Ichihara Atsuhiro

Background: Growth hormone (GH) deficiency, which causes visceral obesity and non-alcohol fatty liver disease, increases cardiovascular event risks. High-sensitivity C-reactive protein (hs-CRP), an inflammatory marker associated with increased cardiovascular risk, reportedly decreased after GH supplementation in GH-deficient patients, however, the association between GH secretion and inflammation remains unclear.Patients and Methods: We retrospectively i...

ea0037ep717 | Pituitary: clinical | ECE2015

Isolated pituitary sarcoidosis stained with a specific MAB against Propionibacterium acnes: a case report

Yamashita Kaoru , Niiyama Michita , Seki Yasufumi , Watanabe Daisuke , Isozaki Osamu , Amano Kosaku , Komori Takashi , Okada Yoshikazu , Eishi Yoshinobu , Ichihara Atsuhiro

Introduction: Sarcoidosis is a systemic granulomatous disorder usually affects multiple organs. Approximately 10% of sarcoidosis occurs as isolated neurosarcoidosis in CNS and <10% of neurosarcoidosis develops in a restricted hypothalamic–pituitary area. Recent study has identified Propionibacterium acnes in lungs and lymph nodes of many patients with sarcoidosis using a MAB specific for this bacterium (PAB), providing strong evidence for P. acne as ...

ea0081p158 | Pituitary and Neuroendocrinology | ECE2022

Effect of growth hormone deficiency on serum high-sensitivity C-reactive protein levels in adult patients with non-functioning pituitary tumors

Seki Yasufumi , Takano Noriyoshi , Yamashita Kaoru , Bokuda Kanako , Sasaki Nobukazu , Ishikawa Toru , Kimura Miwa , Watanabe Satoshi , Watanabe Daisuke , Morimoto Satoshi , Ichihara Atsuhiro

Background: Growth hormone (GH) deficiency causes visceral obesity and fatty liver and increases cardiovascular event risks. Because serum high-sensitivity C-reactive protein (hs-CRP) levels, which has been used to estimate those risks, was reported to be decreased by GH supplementation therapy in GH deficient patients, it has been suggested that inflammatory processes might be activated in GH deficient state. However, the clinical factors associated with increased hs-CRP leve...

ea0037ep1206 | Clinical Cases–Pituitary/Adrenal | ECE2015

Effectiveness of octoreotide administration before surgery for GH-TSH co-secreting pituitary adenoma with thyrotoxicosis: a case report

Kimura Shihori , Isozaki Osamu , Fukuda Izumi , Morimoto Satoshi , Seki Yasufumi , Yamashita Kaoru , Takano Noriyoshi , Otsuki Akiko , Kaneshige Terumi , Bokuda Kanako , Watanabe Daisuke , Ando Takashi , Hizuka Naomi , Amano Kosaku , Komori Takashi , Okada Yoshikazu , Ichihara Atsuhiro

Introduction: TSH-secreting pituitary adenoma (TSHoma) sometimes brings on rare cause of hyperthyroidism because of its excessive TSH secretion. Though the first line of treatment for TSHoma is surgical removal of tumour, hyperthyroidism often causes perioperative thyroid storm. Here, we report a case of GH-TSH pituitary adenoma whose thyrotoxicosis was controlled by 5 days’ octoreotide (OCT) subcutaneous administration before surgery.Case report: A...